Prevent Payers from Dictating Pain Care Pathway

Peripheral nerve stimulation is effective. The only reason an insurance company would deny coverage is cost. Do the right thing.

Provides a novel therapy for patients who otherwise do no have good treatment options for intractable pain. It's the right thing to do.

This treatment has been so beneficial for my patients that have exhausted several treatment modalities and sometimes even surgery. It will be disservice to take such and effective non narcotic treatment modality away from patients.

PNS is a viable alternative that should not be excluded from insurance coverage, especially given the concern for long-term opioid use in non-malignant chronic pain.

This therapy has been a GAME CHANGER for patients. No longer do patients require a perm medical implant nor surgery to get sustained pain relief for neuropathy. It would be criminal to not allow access to this therapy for patients.

Strong data to support efficacy! Alternative to addictive and dangerous opioids.

Much needed therapy that fills a treatment gap and offers a non-surgical option to reduce pain, improve function and reduce the opioid burden.

PNS is a very important treatment modularity for our patients especially during the opioid crisis which has once again worsened with the pandemic.

This technology is life changing in the correct patient and requires little to no post procedure recovery.

Peripheral nerve stimulation is a very valuable therapy for select patients who do not respond to traditional pain management strategies. It can also help alleviate the long term side effects from opioid therapy.

This is an important therapy for may pain indications and is extremely valuable in decreasing or eliminating opioid use.

I’m in agreement!

Peripheral nerve stimulation is one of the few tools we have for persistent pain. Please don't leave patient's hanging!

Any such decision about withholding Peripheral Nerve Stimulation will add to the opioid epidemic and will take vital pain treatment options away from the patients.

Please re-consider this detrimental change to reimbursement. Pain management has made great strides in providing life changing pain control options that do NOT include opioids. We are making a difference in a positive direction. Please don’t create obstacles to this common goal.

This is a safe and effective treatment . It has provided a much safer alternative .

PNS is a proven safe opioid sparing technology for peri operative, acute, and chronic pain. This is a cost saving procedure that improves patients quality of life and decreases lifetime medical cost.

Already happening at my insititition. Their reimbursement is half of Medicare’s

PNS must remain an option for chronic pain patient.

This minimally invasive therapy has been proven to reduce the opioids required and is FDA proven to be safe and effective as a therapy for many chronic pain conditions. What is the alternative? If you deny this coverage, what do you suggest we do instead? Do you prefer physicians escalate narcotics, or patients to suffer in pain? This therapy is effective and inexpensive compared to the alternative cost of potential harm from opioids and/or patient suffering.